Literature DB >> 6271368

Effects of a methyl-deficient diet on rat liver phosphatidylcholine biosynthesis.

D R Hoffman, J A Haning, W E Cornatzer.   

Abstract

To produce a severe choline-methionine deficiency, a synthetic L-amino acid diet, free of choline, methionine, vitamin B12, and folic acid and supplemented with guanidoacetic acid, a methyl group acceptor, was fed to female rats for 2 weeks. The in vitro activity of liver microsomal phosphatidylethanolamine methyltransferase was stimulated twofold when compared with basal diet controls. The activity of choline phosphotransferase was depressed by 86%; thus, the contribution of the methyltransferase in the overall synthesis of phosphatidylcholine apparently increased. However, measurement of the in vivo methylation of phosphatidylethanolamine by incorporation of [1,2-14C]ethanolamine into phosphatidylcholine indicates that the methylation pathway is markedly depressed in methyl deficiency. Hepatic concentrations of the methyltransferase substrate, S-adenosylmethionine, and the inhibitory metabolite, S-adenosylhomocysteine, were significantly altered such that an unfavorable environment for methylation was present in the deficient animal. The ratio of substrate to inhibitor was depressed from 5.2:1 in the controls to 1.7:1 in the livers of methyl-depleted rats. Control of transmethylation in accordance with the availability of substrates, phosphatidylethanolamine, or S-adenosylmethionine, and the level of S-adenosylhomocysteine is discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6271368     DOI: 10.1139/o81-075

Source DB:  PubMed          Journal:  Can J Biochem        ISSN: 0008-4018


  11 in total

1.  Progression of prostate carcinogenesis and dietary methyl donors: temporal dependence.

Authors:  Shabana Shabbeer; Simon A Williams; Brian W Simons; James G Herman; Michael A Carducci
Journal:  Cancer Prev Res (Phila)       Date:  2011-12-02

2.  The incorporation of monomethylethanolamine and dimethylethanolamine in fetal brain aggregating cell culture.

Authors:  F Dainous; J N Kanfer
Journal:  Neurochem Res       Date:  1988-01       Impact factor: 3.996

3.  Sexually dimorphic activation of liver and brain phosphatidylethanolamine N-methyltransferase by dietary choline deficiency.

Authors:  P I Johnson; J K Blusztajn
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

4.  Effect of choline deficiency on S-adenosylmethionine and methionine concentrations in rat liver.

Authors:  S H Zeisel; T Zola; K A daCosta; E A Pomfret
Journal:  Biochem J       Date:  1989-05-01       Impact factor: 3.857

5.  Docosahexaenoic acid in plasma phosphatidylcholine may be a potential marker for in vivo phosphatidylethanolamine N-methyltransferase activity in humans.

Authors:  Kerry-Ann da Costa; Lisa M Sanders; Leslie M Fischer; Steven H Zeisel
Journal:  Am J Clin Nutr       Date:  2011-03-16       Impact factor: 7.045

Review 6.  Choline nutrition programs brain development via DNA and histone methylation.

Authors:  Jan Krzysztof Blusztajn; Tiffany J Mellott
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2012-06

7.  The effect of embryological development on phosphatidylethanolamine methyltransferase, phosphatidyldimethylethanolamine methyltransferase and choline phosphotransferase of rabbit liver microsomes.

Authors:  W E Cornatzer; D R Hoffman; J A Haning
Journal:  Lipids       Date:  1984-01       Impact factor: 1.880

8.  Effect of pyridoxine deficiency on phospholipid methylation in rat liver microsomes.

Authors:  G Loo; J T Smith
Journal:  Lipids       Date:  1986-06       Impact factor: 1.880

9.  Phosphatidylcholine synthesis in the rat: the substrate for methylation and regulation by choline.

Authors:  A H Datko; R R Aksamit; S H Mudd
Journal:  Lipids       Date:  1990-03       Impact factor: 1.880

10.  Effect of zinc deficiency on the biosynthesis of phosphatidylcholine in rat microsomes.

Authors:  W E Cornatzer; J A Haning; J C Wallwork; H H Sandstead
Journal:  Biol Trace Elem Res       Date:  1984-10       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.